$95.35
0.02% today
NYSE, May 15, 04:47 pm CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Stock price

$95.33
-6.64 6.51% 1M
-13.52 12.42% 6M
-10.30 9.75% YTD
-24.64 20.54% 1Y
-19.79 17.19% 3Y
-13.42 12.34% 5Y
-14.85 13.48% 10Y
NYSE, Closing price Wed, May 14 2025
-2.16 2.22%
ISIN
US98956P1021
Symbol
ZBH
Sector

Key metrics

Market capitalization $18.86b
Enterprise Value $24.66b
P/E (TTM) P/E ratio 21.13
EV/FCF (TTM) EV/FCF 19.84
EV/Sales (TTM) EV/Sales 3.20
P/S ratio (TTM) P/S ratio 2.45
P/B ratio (TTM) P/B ratio 1.52
Dividend yield 1.01%
Last dividend (FY24) $0.96
Revenue growth (TTM) Revenue growth 3.30%
Revenue (TTM) Revenue $7.70b
EBIT (operating result TTM) EBIT $1.44b
Free Cash Flow (TTM) Free Cash Flow $1.24b
Cash position $1.38b
EPS (TTM) EPS $4.51
P/E forward 20.57
P/S forward 2.31
EV/Sales forward 3.01
Short interest 3.63%
Show more

Is Zimmer Biomet Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Zimmer Biomet Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

32 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

13x Buy
41%
17x Hold
53%
2x Sell
6%

Analyst Opinions

32 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

Buy
41%
Hold
53%
Sell
6%

Financial data from Zimmer Biomet Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
7,699 7,699
3% 3%
100%
- Direct Costs 2,901 2,901
5% 5%
38%
4,797 4,797
2% 2%
62%
- Selling and Administrative Expenses 1,904 1,904
1% 1%
25%
- Research and Development Expense 440 440
4% 4%
6%
2,454 2,454
4% 4%
32%
- Depreciation and Amortization 1,012 1,012
6% 6%
13%
EBIT (Operating Income) EBIT 1,441 1,441
3% 3%
19%
Net Profit 913 913
5% 5%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Zimmer Biomet Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zimmer Biomet Holdings, Inc. Stock News

Neutral
Seeking Alpha
9 days ago
Zimmer Biomet's stock dropped nearly 10% on the back of soft Q1 results. Despite structural tailwinds, Zimmer Biomet's business is struggling in the face of high interest rates, trade tensions and competition. Zimmer Biomet's cash flows appear set to be particularly hard hit by tariffs, meaning the company's share price is likely to remain depressed until this is resolved.
Neutral
Seeking Alpha
10 days ago
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET Company Participants David DeMartino - SVP, IR Ivan Tornos - President & CEO Suketu Upadhyay - CFO & EVP, Finance, Operations & Supply Chain Conference Call Participants Robbie Marcus - JPMorgan David Roman - Goldman Sachs Chris Pasquale - Nephron Matthew O'Brien - Piper Sandler Matthew Taylor - Jef...
Negative
Reuters
10 days ago
Zimmer Biomet Holdings on Monday lowered its full-year adjusted profit forecast, as the medical device maker anticipates a hit from its recent acquisition of Paragon 28 , currency volatility, and proposed tariffs.
More Zimmer Biomet Holdings, Inc. News

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Head office United States
CEO Ivan Tornos
Employees 17,000
Founded 1927
Website www.zimmerbiomet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today